Navigation Links
Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy
Date:12/3/2010

ATLANTA, Dec. 3, 2010 /PRNewswire/ -- Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration for its XiO® treatment planning software to plan spot scanning. Spot scanning is a proton therapy delivery method that involves constructing a highly conformal dose to the tumor by using thousands of small individual beamlets instead of a single large beam. This approach enables Intensity Modulated Proton Therapy (IMPT).

XiO, Elekta's 3D / Intensity Modulated Radiation Therapy (IMRT) treatment planning platform, offers proton therapy centers another option to plan proton deliveries. XiO provides unique tools to facilitate rapid positioning of spots to construct the dose to the tumor, in addition to a proven dose calculation algorithm to optimize each beam.

"The completely automated optimization of the spot deliveries allows clinicians to produce treatment plans with a high degree of conformality around the target, therefore, minimizing the dose to adjacent healthy tissue," says Virgil Willcut, Vice President of Product Management, Physics & Research for Elekta Treatment Planning. "Spot scanning especially is important for pediatric patients since it provides better normal tissue sparing and lower neutron doses than conventional proton planning, both of which reduce the chance of radiation induced side effects for a cohort of patients that are still developing and have long life expectancies."

In clinical use for nearly a decade, XiO is in use at more proton facilities than any other commercial vendor with a similar product. To learn more about Elekta's XiO treatment planning software, visit www.elekta.com/PT-treatmentplanning.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology
2. Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference
3. Healthcare Providers Rate Elektas MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report
4. Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer
5. Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser
6. Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community
7. Treatment with Elektas Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
8. Elekta Earns Top Customer Marks from MD Buyline for 2nd Quarter 2010
9. Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Centers Installment of Elektas Leksell Gamma Knife Perfexion
10. Prostate Cancer Patients Benefit from New Zealand Centers Adoption of Elekta VMAT Radiotherapy Technique
11. Stereotactic Body Radiation Therapy for Lung Cancer a Key Topic for Elekta Presenters at Annual ASTRO Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):